Treatment of chromoblastomycosis with terbinafine: Experience with four cases

References

• McGinnis MR, Hill CH. Chromoblastomycosis and phaeo- hyphomycosis: new concepts, diagnosis, and mycology. J Am Acad Dermatol 1983;8:1–16.
   PubMed Web of Science ®Google Scholar
• Rippon JW. Chromoblastomycosis. In: Medical Mycology. The Pathogenic Fungi and the Pathogenic Actinomycetes. Philadelphia: WB Saunders, 1988. p 276–96.
   Google Scholar
• Lavalle P. Chromomycosis. In: Can˜ izares O, editor. Clinical Tropical Dermatology. London: Blackwell Scientific Publications, 1975. p 36–41.
   Google Scholar
• Arenas R. Chromoblastomycosis. In: Jacobs PH, Nall L, editors. Antifungal Drug Therapy: A Complete Guide for the Practitioner. New York: Marcel-Dekker, 1990. p 43–50.
   Google Scholar
• Elgart GW. Chromoblastomycosis. Dermatol Clin 1996; 14:77–83.
   PubMed Web of Science ®Google Scholar
• Bonifaz A. Chromoblastomycosis. In: Arenas R, Estrada R, editors. Tropical Dermatology. Georgetown, TX: Landes Bioscience, 2001. p 68–71.
   Google Scholar
• Sanche SE, Sutton DA, Rinaldi MG. Dematiaceous fungi. In: Anaissie EJ, McGinnis MR, Pfaller MA, editors. Cli- nical Mycology. New York: Churchill-Livingstone, 2003. p 325–51.
   Google Scholar
• Bonifaz A, Carrasco-Gerard E, Sau´ l A. Chromoblastomycosis: a clinical and mycological experience of 51 cases. Mycoses 2001;44:1–7.
   Google Scholar
• Restrepo A. Treatment of tropical mycoses. J Am Acad Dermatol 1994;31(suppl 1): S91-102.
   Google Scholar
• Esterre P, Andriantsimahavandy A, Raharisolo C. Natural history of chromoblastomycosis in Madagascar and the Indian Ocean. Bull Soc Pathol Exot 1997;90:312–17.
   PubMed Web of Science ®Google Scholar
• Attapattu MC. Chromoblastomycosis: a clinical and myco- logical study of 71 cases from Sri Lanka. Mycopathologia 1997;137:145–51.
   PubMed Web of Science ®Google Scholar
• Castro LG, Pimentel ER, Lacaz CS. Treatment of chromo- mycosis by cryosurgery with liquid nitrogen: 15 years’ experience. Int J Dermatol 2003;42:408–12.
   PubMed Web of Science ®Google Scholar
• Hiruma M, Kawada A, Yoshida M, Kouya M. Hyperthermic treatment of chromomycosis with disposable chemical pocket warmers. Report of a successfully treated case, with a review of the literature. Mycopathologia 1993;122:107–14.
   Google Scholar
• Kuttner BJ, Siegle RJ. Treatment of chromomycosis with a CO2 laser. J Dermatol Surg Oncol 1986;12:965–8.
   PubMedGoogle Scholar
• Tagami H, Ginoza M, Imaizumi S, et al. Successful treatment of chromoblastomycosis with topical heat therapy. J Am Acad Dermatol 1984;10:615–19.
   PubMed Web of Science ®Google Scholar
• Bonifaz A, Paredes-Sol´ıs V, Sau´ l A. Treating chromoblasto- mycosis with systemic antifungals. Expert Opin Pharmacother 2004;5:247–54.
   PubMed Web of Science ®Google Scholar
• Diaz M, Negroni R, Montero-Gei F, et al. A Pan-American 5-year study of fluconazole therapy for deep mycoses in the immunocompetent host. Pan-American Study Group. Clin Infect Dis 1992;14(suppl 1): S68-76.
   Google Scholar
• Tilnelnot K. Therapy of infections caused by dematiaceous fungi. Mycoses 1997;40:91–6.
   Web of Science ®Google Scholar
• Queiroz-Tellez F, Purim K, Fillus JN, et al. Itraconazole in the treatment of chromoblastomycosis due to Fonsecaea pedrosoi. Int J Dermatol 1992;31:805–12.
   PubMed Web of Science ®Google Scholar
• Bonifaz A, Mart´ınez-Soto E, Carrasco-Gerard E, Peniche J. Treatment of chromoblastomycosis with itraconazole, cryosurgery and combination of both. Int J Dermatol 1997;36:542–7.
   PubMed Web of Science ®Google Scholar
• Ryder NS, Favre B. Antifungal activity and mechanism of action of terbinafine. Rev Contemp Pharmacother 1997;8:275–87.
   Google Scholar
• Hall M, Monka C, Krupp P, O’Sullivan D. Safety of oral terbinafine. Results of a postmarketing surveillance study in 25 884 patients. Arch Dermatol 1997;133:1213–19.
   Google Scholar
• Pe´rez A. Terbinafine: broad new spectrum of indications in several subcutaneous and systemic and parasitic diseases. Mycoses 1999;42(suppl 2):111-14.
   Google Scholar
• Hay RJ. Therapeutic potential of terbinafine in subcuta- neous and systemic mycoses. Br J Dermatol 1999;141(suppl 56):36-40.
   Google Scholar
• Esterre P, Inzan CK, Ramarcel ER, et al. Treatment of chromomycosis with terbinafine: preliminary results of an open pilot study. Br J Dermatol 1996;134(suppl 46):33-6.
   Google Scholar
• Esterre P, Ratsioharama M, Roig P. Potential use of terbinafine in the treatment of chromoblastomycosis. Rev Contemp Pharmacother 1997;8:357–61.
   Google Scholar
• Sevigny GM, Ramos-Caro FA. Treatment of chromo- blastomycosis due to Fonsecaea pedrosoi with low-dose terbinafine. Cutis 2000;66:45–6.
   PubMed Web of Science ®Google Scholar
• Tanuma H, Hiratsu M, Mukai H, et al. A case of chromoblastomycosis effectively treated with terbinafine. Characteristics of chromoblastomycosis in the Kitasato region, Japan. Mycoses 2000;43:79–83.
   Google Scholar
• Hussain I, Rashid T, Haroon TS. Parenteral vitamin D(3) and oral terbinafine for refractory chromoblastomycosis. Br J Dermatol 2002;146:704.
   PubMed Web of Science ®Google Scholar
• McGinnis MR, Pasarell L. In vitro evaluation of terbinafine and itraconazole against dematiaceous fungi. Med Mycol 1998;36:243–6.
   PubMed Web of Science ®Google Scholar
• Caligiorne RB, Resende MA, Melillo PH, et al. In vitro susceptibility of chromoblastomycosis and phaeohyphomy- cosis agents to antifungal drugs. Med Mycol 1999;37:405–9.
   PubMed Web of Science ®Google Scholar
• Bedout C, Go´ mez BL, Restrepo A. In vitro susceptibility testing of Fonsecaea pedrosoi to antifungals. Rev Inst Med Trop Sao Paulo 1997;39:145–8.
   PubMedGoogle Scholar
• Gupta AK, Taborda PR, Sanzovo AD. Alternate week and combination itraconazole and terbinafine therapy for chromoblastomycosis caused by Fonsecaea pedrosoi in Brazil. Med Mycol 2002;40:529–34.
   PubMed Web of Science ®Google Scholar